Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement

EuroIntervention

Volumn 9, Issue 8, 2013, Pages 929-935

  Barbanti, Marco ^a   Binder, Ronald K ^a   Freeman, Melanie ^a   Wood, David A ^a   Leipsic, Jonathon ^a   Cheung, Anson ^a   Ye, Jian ^a   Tan, John ^a   Toggweiler, Stefan ^a   Yang, Tae Hyun ^a   Dvir, Danny ^a   Maryniak, Kasia ^a   Lauck, Sandra ^a   Webb, John G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTERY DIAMETER; ARTICLE; CATHETER COMPLICATION; CATHETER SHEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FALSE ANEURYSM; FEMALE; FEMORAL DISSECTION; FEMORAL OCCLUSION; HUMAN; LIFE THREAT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTION; RETROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84892941803     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9I8A156     Document Type: Article

References (17)

1. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the Sapien aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation. 2010;122:62-9.
2. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-90.
3. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW, Babaliaros V, Bavaria JE, Velazquez OC, Williams MR, Hueter I, Xu K, Leon MB; PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043-52.
4. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. Percutaneous aortic valve replacement. Vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113-8.
5. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851-8.
6. Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hutter A, Tassani-Prell P, Laborde JC, Bauernschmitt R. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg. 2011;40:1105-13.
7. Freeman M, Rodes-Cabau J, Urena M, Delarochelliere R, Dumont E, Masson JB, Willson AB, Binder RK, Toggweiler S, Leipsic J, Wood DA, Webb JG. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve. Catheter Cardiovasc Interv. 2013;82:664-70.
8. Genereux P, Kodali S, Leon MB, Smith CR, Ben-Gal Y, Kirtane AJ, Daneault B, Reiss GR, Moses JW, Williams MR. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv. 2011;4:861-7.
9. Curran H, Chieffo A, Buchanan GL, Bernelli C, Montorfano M, Maisano F, Latib A, Maccagni D, Carlino M, Figini F, Cioni M, La Canna G, Covello RD, Franco A, Gerli C, Alfieri O, Colombo A. A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: The Milan experience. Catheter Cardiovasc Interv. 2013 Mar 8. [Epub ahead of print].
10. Kappetein AP, Head SJ, Généreux P, Piazza N, vanMieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention. 2012;8:782-95.
11. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv. 2009;2:811-20.
12. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011;32:140-7.
13. Stortecky S, Wenaweser P, Diehm N, Pilgrim T, Huber C, Rosskopf AB, Khattab AA, Buellesfeld L, Gloekler S, Eberle B, Schmidli J, Carrel T, Meier B, Windecker S. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:515-24.
14. Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Hutter A, Laborde JC, Bauernschmitt R, Lange R. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg. 2009;35:615-20.
15. Buchanan GL, Chieffo A, Montorfano M, Maccagni D, Maisano F, Latib A, Covello RD, Grimaldi A, Alfieri O, Colombo A. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention. 2011;7:556-63.
16. Humphries KH, Toggweiler S, Rodés-Cabau J, Nombela- Franco L, Dumont E, Wood DA, Willson AB, Binder RK, Freeman M, Lee MK, Gao M, Izadnegahdar M, Ye J, Cheung A, Webb JG. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2012;60:882-6.
17. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac sur-gery. Circulation. 2007;116:2544-52.